top of page


We are seeking investors and partners to join with us in raising capital toward the following industry solutions: 

JUNO AI-Based Viral Surveillance Platform:  

       COVID-19 Edition : JunoCOVID-Dx - a Rapid SARS CoV-2 Solution

A rapid, mobile metabolomics-based solution for diagnosing Covid-19 at scale that accounts for genetic viral mutations, enables personalized treatment and prevention, and tracks / predicts outbreaks via AI-enhanced automated data tracing. JUNO Metabolomics is partnering with U.S. military healthcare organizations in order to bring mass-testing capability to the armed forces and general public.

                                                     *Request more information for investors: 


bottom of page